Japan Ophthalmic Viscoelastic Devices Market Size, Share, and COVID-19 Impact Analysis, By Product (Cohesive OVD and Dispersive OVD), By Application (Cataract Surgery, Glaucoma Surgery, Corneal Transplant, and Vitreoretinal Surgery), and Japan Ophthalmic Viscoelastic Devices Market Insights, Industry Trend, Forecasts to 2033
Industry: HealthcareJapan Ophthalmic Viscoelastic Devices Market Insights Forecasts to 2033
- The Japan Ophthalmic Viscoelastic Devices Market Size was valued at USD 0.17 Billion in 2023.
- The Market Size is Growing at a CAGR of 5.12% from 2023 to 2033
- The Japan Ophthalmic Viscoelastic Devices Market Size is Expected to Reach USD 0.28 Billion by 2033
Get more details on this report -
The Japan Ophthalmic Viscoelastic Devices Market Size is Anticipated to Reach USD 0.28 Billion by 2033, Growing at a CAGR of 5.12% from 2023 to 2033.
Market Overview
Japan ophthalmic viscoelastic devices market refers to the segment of the medical Devices industry that produces and distributes viscoelastic substances used during ophthalmic surgeries, such as cataract or glaucoma procedures. These devices, which include substances like sodium hyaluronate, are essential for maintaining eye shape and protecting delicate structures during surgery. Additionally, advancements in OVD technology, such as the development of higher viscosity formulations and bio-compatible materials, have further fueled market expansion. The Japanese government has been supportive of the medical Devices sector through various initiatives, including the promotion of advanced healthcare technology under the Health and Medical Strategy. In addition, there are several reimbursement schemes that help make ophthalmic surgeries more affordable for the aging population, driving demand for such devices. Regulatory frameworks and technological investments have been designed to foster innovation while ensuring high patient safety standards, positioning Japan as a leading market for ophthalmic surgical products in Asia.
Report Coverage
This research report categorizes the Japan ophthalmic viscoelastic devices market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Japan ophthalmic viscoelastic devices market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Japan ophthalmic viscoelastic devices market.
Japan Ophthalmic Viscoelastic Devices Market Report Coverage
Report Coverage | Details |
---|---|
Base Year: | 2023 |
Market Size in 2023: | USD 0.17 Billion |
Forecast Period: | 2023-2033 |
Forecast Period CAGR 2023-2033 : | 5.12% |
2033 Value Projection: | USD 0.28 Billion |
Historical Data for: | 2019-2022 |
No. of Pages: | 215 |
Tables, Charts & Figures: | 112 |
Segments covered: | By Product, By Application and COVID-19 Impact Analysis |
Companies covered:: | Baush+Lomb, CIMA Product Inc, RUMEX International Co, ZEISS Group, Bohus BioTech AB, Eyekon Medical, Alcon Inc., Johnson & Johnson, Seikagaku Corporation, Rayner Group., and Others key Vendors |
Pitfalls & Challenges: | COVID-19 Empact, Challenge, Future, Growth, & Analysis. |
Get more details on this report -
Driving Factors
Japan has one of the highest rates of cataract surgeries globally, further boosting the need for advanced ophthalmic surgical devices. Technological advancements in OVD formulations, including the development of high-viscosity, longer-lasting, and biocompatible materials, have enhanced the effectiveness and safety of surgeries, encouraging their adoption. Moreover, increasing awareness of eye health and the rising demand for vision correction among the elderly population have contributed to the market's expansion.
Restraining Factors
One of the primary challenges is the high cost associated with advanced OVD formulations, which may limit their affordability, particularly for smaller healthcare facilities or patients without comprehensive insurance coverage.
Market Segmentation
The Japan ophthalmic viscoelastic devices market share is classified into product and application.
- The cohesive OVD segment accounted for the largest market share in 2023 and is expected to grow at a remarkable CAGR during the forecast period.
The Japan ophthalmic viscoelastic devices market is segmented by product into cohesive OVD and dispersive OVD. Among these, the cohesive OVD segment accounted for the largest market share in 2023 and is expected to grow at a remarkable CAGR during the forecast period. The segment growth is driven as cohesive OVDs are preferred in ophthalmic surgeries, particularly in cataract procedures, due to their superior ability to maintain eye shape, protect delicate tissues, and provide better control during surgery. These devices are known for their high viscosity and minimal spread, which helps prevent the collapse of the anterior chamber and protects the corneal endothelium.
- The cataract surgery segment accounted for the leading market share in 2023 and is expected to grow at a significant CAGR during the forecast period.
The Japan ophthalmic viscoelastic devices market is segmented by application into cataract surgery, glaucoma surgery, corneal transplant, and vitreoretinal surgery. Among these, the cataract surgery segment accounted for the leading market share in 2023 and is expected to grow at a significant CAGR during the forecast period. The segment growth is driven by the country’s aging population, which has a high prevalence of cataracts. OVDs play a critical role in cataract procedures by maintaining the eye’s shape, protecting the corneal endothelium, and facilitating the implantation of intraocular lenses (IOLs).
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the Japan ophthalmic viscoelastic devices market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
List of Key Companies
- Baush+Lomb
- CIMA Product Inc
- RUMEX International Co
- ZEISS Group
- Bohus BioTech AB
- Eyekon Medical
- Alcon Inc.
- Johnson & Johnson
- Seikagaku Corporation
- Rayner Group.
- Others
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Market Segment
This study forecasts revenue at Japan, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the Japan ophthalmic viscoelastic devices market based on the below-mentioned segments:
Japan Ophthalmic Viscoelastic Devices Market, By Product
- Cohesive OVD
- Dispersive OVD
Japan Ophthalmic Viscoelastic Devices Market, By Application
- Cataract Surgery
- Glaucoma Surgery
- Corneal Transplant
- Vitreoretinal Surgery
Need help to buy this report?